MedTrace Logo

Prevalence and Impact in Work Productivity of Gastroesophageal Reflux Disease (GERD) in Primary Care Patients With Upper Gastrointestinal (GI) Symptoms Using GerdQ

NCT00914342 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 889

Last updated 2009-12-29

No results posted yet for this study

Summary

The purpose of the study is to provide data on the GERD prevalence as percentage of patients with upper GI symptoms that are identified with GERD using the GerdQ Questionnaire. Furthermore the study aims to estimate GERD prevalence in patients based on their symptoms as they respond to a physician's questionnaire, to observe possible variations between the two methods (physicians' symptom rating and GerdQ), to objectively measure treatment response and to identify the percentage of patients that may require alterations of their treatment. Finally, to describe the impact of GERD symptoms on work productivity.

Conditions

  • Gastroesophageal Reflux Disease

Sponsors & Collaborators

Principal Investigators

  • Theodoros Rokkas, Dr · Henry Dynan Hospital, Athens, Greece

  • Panagiotis Pontikis, Dr · AstraZeneca Greece

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Completion
2009-12-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00914342 on ClinicalTrials.gov